The Safety and Efficacy Study of Avatrombopag Switch in TPO-RA Refractory AA
Clinical trial NCT05518331 · UNKNOWN
Trial details
- NCT number
- NCT05518331
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2025-06-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.